These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7608153)

  • 1. Arginine 206 of the C5a receptor is critical for ligand recognition and receptor activation by C-terminal hexapeptide analogs.
    DeMartino JA; Konteatis ZD; Siciliano SJ; Van Riper G; Underwood DJ; Fischer PA; Springer MS
    J Biol Chem; 1995 Jul; 270(27):15966-9. PubMed ID: 7608153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
    Wong AK; Finch AM; Pierens GK; Craik DJ; Taylor SM; Fairlie DP
    J Med Chem; 1998 Aug; 41(18):3417-25. PubMed ID: 9719594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74).
    Cain SA; Monk PN
    J Biol Chem; 2002 Mar; 277(9):7165-9. PubMed ID: 11773063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the ligand-binding site on the C5a receptor: arginine74 of C5a contacts aspartate282 of the C5a receptor.
    Cain SA; Coughlan T; Monk PN
    Biochemistry; 2001 Nov; 40(46):14047-52. PubMed ID: 11705397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptor.
    Cain SA; Woodruff TM; Taylor SM; Fairlie DP; Sanderson SD; Monk PN
    Biochem Pharmacol; 2001 Jun; 61(12):1571-9. PubMed ID: 11377387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor.
    Raffetseder U; Röper D; Mery L; Gietz C; Klos A; Grötzinger J; Wollmer A; Boulay F; Köhl J; Bautsch W
    Eur J Biochem; 1996 Jan; 235(1-2):82-90. PubMed ID: 8631370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus.
    Monk PN; Barker MD; Partridge LJ; Pease JE
    J Biol Chem; 1995 Jul; 270(28):16625-9. PubMed ID: 7622471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C5aR ligand peptide 3D QSAR study performed with an applied linear conformation.
    Anderson CY; Kellogg GE; Freer RJ
    J Pept Res; 1997 Jun; 49(6):476-83. PubMed ID: 9266474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An activation switch in the ligand binding pocket of the C5a receptor.
    Gerber BO; Meng EC; Dotsch V; Baranski TJ; Bourne HR
    J Biol Chem; 2001 Feb; 276(5):3394-400. PubMed ID: 11062244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin.
    Chen Z; Zhang X; Gonnella NC; Pellas TC; Boyar WC; Ni F
    J Biol Chem; 1998 Apr; 273(17):10411-9. PubMed ID: 9553099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human complement 5a (C5a) anaphylatoxin receptor (CD88) phosphorylation sites and their specific role in receptor phosphorylation and attenuation of G protein-mediated responses. Desensitization of C5a receptor controls superoxide production but not receptor sequestration in HL-60 cells.
    Christophe T; Rabiet MJ; Tardif M; Milcent MD; Boulay F
    J Biol Chem; 2000 Jan; 275(3):1656-64. PubMed ID: 10636859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor.
    Bubeck P; Grötzinger J; Winkler M; Köhl J; Wollmer A; Klos A; Bautsch W
    Eur J Biochem; 1994 Feb; 219(3):897-904. PubMed ID: 8112341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation.
    McCoy R; Haviland DL; Molmenti EP; Ziambaras T; Wetsel RA; Perlmutter DH
    J Exp Med; 1995 Jul; 182(1):207-17. PubMed ID: 7540650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that the extracellular N-terminal domain of C5aR contains amino-acid residues crucial for C5a binding.
    Mery L; Boulay F
    Eur J Haematol; 1993 Nov; 51(5):282-7. PubMed ID: 8282089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Random mutagenesis of the complement factor 5a (C5a) receptor N terminus provides a structural constraint for C5a docking.
    Hagemann IS; Narzinski KD; Floyd DH; Baranski TJ
    J Biol Chem; 2006 Dec; 281(48):36783-92. PubMed ID: 17023413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope mapping of a C5a neutralizing mAb using a combined approach of phage display, synthetic peptides and site-directed mutagenesis.
    Kola A; Baensch M; Bautsch W; Hennecke M; Klos A; Casaretto M; Köhl J
    Immunotechnology; 1996 Jun; 2(2):115-26. PubMed ID: 9373320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative agonist/antagonist responses in mutant human C5a receptors define the ligand binding site.
    Higginbottom A; Cain SA; Woodruff TM; Proctor LM; Madala PK; Tyndall JD; Taylor SM; Fairlie DP; Monk PN
    J Biol Chem; 2005 May; 280(18):17831-40. PubMed ID: 15661745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C5A anaphylatoxin and its seven transmembrane-segment receptor.
    Gerard C; Gerard NP
    Annu Rev Immunol; 1994; 12():775-808. PubMed ID: 8011297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic mapping of the human C5a receptor. Identification of transmembrane amino acids critical for receptor function.
    Geva A; Lassere TB; Lichtarge O; Pollitt SK; Baranski TJ
    J Biol Chem; 2000 Nov; 275(45):35393-401. PubMed ID: 10952985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor activation by human C5a des Arg74 but not intact C5a is dependent on an interaction between Glu199 of the receptor and Lys68 of the ligand.
    Crass T; Bautsch W; Cain SA; Pease JE; Monk PN
    Biochemistry; 1999 Jul; 38(30):9712-7. PubMed ID: 10423250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.